These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37400842)
1. BCR::ABL1-like acute lymphoblastic leukaemia: a single institution experience on identification of potentially therapeutic targetable cases. Płotka A; Przybyłowicz-Chalecka A; Korolczuk M; Kanduła Z; Ratajczak B; Kiernicka-Parulska J; Mierzwa A; Godziewska K; Jarmuż-Szymczak M; Gil L; Lewandowski K Mol Cytogenet; 2023 Jul; 16(1):14. PubMed ID: 37400842 [TBL] [Abstract][Full Text] [Related]
2. BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy. Płotka A; Lewandowski K Acta Haematol; 2022; 145(2):122-131. PubMed ID: 34818644 [TBL] [Abstract][Full Text] [Related]
3. Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on Hrabovsky S; Vrzalova Z; Stika J; Jelinkova H; Jarosova M; Navrkalova V; Martenek J; Folber F; Salek C; Horacek JM; Pospisilova S; Mayer J; Doubek M Acta Oncol; 2021 Jun; 60(6):760-770. PubMed ID: 33750258 [TBL] [Abstract][Full Text] [Related]
4. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. van der Veer A; Waanders E; Pieters R; Willemse ME; Van Reijmersdal SV; Russell LJ; Harrison CJ; Evans WE; van der Velden VH; Hoogerbrugge PM; Van Leeuwen F; Escherich G; Horstmann MA; Mohammadi Khankahdani L; Rizopoulos D; De Groot-Kruseman HA; Sonneveld E; Kuiper RP; Den Boer ML Blood; 2013 Oct; 122(15):2622-9. PubMed ID: 23974192 [TBL] [Abstract][Full Text] [Related]
5. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort. Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease. Roberts KG; Pei D; Campana D; Payne-Turner D; Li Y; Cheng C; Sandlund JT; Jeha S; Easton J; Becksfort J; Zhang J; Coustan-Smith E; Raimondi SC; Leung WH; Relling MV; Evans WE; Downing JR; Mullighan CG; Pui CH J Clin Oncol; 2014 Sep; 32(27):3012-20. PubMed ID: 25049327 [TBL] [Abstract][Full Text] [Related]
7. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia. Thakral B; Jain N; Tang G; Konoplev S; Vega F; Medeiros LJ; Wang SA Ann Diagn Pathol; 2021 Aug; 53():151767. PubMed ID: 34118580 [TBL] [Abstract][Full Text] [Related]
8. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics. Sánchez R; Ribera J; Morgades M; Ayala R; Onecha E; Ruiz-Heredia Y; Juárez-Rufián A; de Nicolás R; Sánchez-Pina J; Vives S; Zamora L; Mercadal S; Coll R; Cervera M; García O; Ribera JM; Martínez-López J Blood Cancer J; 2020 Apr; 10(4):43. PubMed ID: 32332702 [TBL] [Abstract][Full Text] [Related]
9. Mucin 4 protein is expressed in B-acute lymphoblastic leukemia and is restricted to BCR::ABL1-positive and BCR::ABL-like subtypes. Gestrich CK; De Lancy SJ; Kresak A; Sinno MG; Yalley A; Pateva I; Meyerson H; Shetty S; Oduro KA Hum Pathol; 2023 Jun; 136():75-83. PubMed ID: 37023866 [TBL] [Abstract][Full Text] [Related]
10. High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia. Lee JW; Kim Y; Cho B; Kim S; Jang PS; Lee J; Cho H; Lee GD; Chung NG; Kim M Cancer Med; 2020 Jul; 9(13):4632-4639. PubMed ID: 32378810 [TBL] [Abstract][Full Text] [Related]
11. IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1-like B-acute lymphoblastic leukaemia. Gestrich CK; De Lancy SJ; Kresak A; Meyerson H; Pateva I; Yalley AK; Ryder C; Shetty S; Bledsoe J; Moore EM; Oduro KA Br J Haematol; 2024 Jan; 204(1):229-239. PubMed ID: 37871900 [TBL] [Abstract][Full Text] [Related]
12. A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript. Mroczkowska A; Jaźwiec B; Urbańska-Rakus J; Szymanowska S; Tessmann A; Pająk S; Machnik K; Haus O; Wróbel T BMC Med Genomics; 2022 Feb; 15(1):20. PubMed ID: 35123463 [TBL] [Abstract][Full Text] [Related]
13. Clinico-hematological and Outcome Profile of Pediatric B-other-ALL and BCR::ABL1-like pre-B-ALL: An Integrated Genomic Study From North India. Peyam S; Bhatia P; Singh M; Sharma P; Sreedharanunni S; Sachdeva MS; Naseem S; Bansal D; Varma N; Thakur R; Trehan A Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e667-e679. PubMed ID: 35484080 [TBL] [Abstract][Full Text] [Related]
14. Laboratory testing in BCR-ABL1-like (Philadelphia-like) B-lymphoblastic leukemia/lymphoma. Siegele BJ; Nardi V Am J Hematol; 2018 Jul; 93(7):971-977. PubMed ID: 29696694 [TBL] [Abstract][Full Text] [Related]